In a new blog on Radiohead's webpage titled "The End of the Beginning," the band announced yesterday that new album In Rainbows would be removed next Monday from the download site set up in October to sell the album. This album has sparked widespread media coverage because of this website and the method used to sell it: without the music industry. The "shut down" of the download site comes as the band prepares to market and sell the album in a more "traditional" way through retail stores, according to NME's reading of the blog.
Billboard also reported that the band has now entered into talks with Apple, Inc. (NASDAQ: AAPL)'s iTunes Store to sell the album in digital stores. It looks like the fan-oriented "pay what you want" feature will certainly be gone for good. Radiohead has apparently resisted a move to the iTunes Store because it allows consumers to "unbundle" albums, breaking up the continuity the band wishes to keep for every album. This has not kept other digital stores from selling Radiohead's albums; they simply do not allow the albums to be cut apart.
The "new" versions of In Rainbows will literally go on sale as the new year begins, with the physical CD release managed and distributed by TBD Records. Radiohead moving into iTunes would add another obvious omission from the store, but it does come at the expense of the experiment the band spearheaded in the last two months. It would be naive to expect any move by the band into iTunes to not follow in the same formatting as the download site had sold. The band's title for the change from their experiment to the "usual" methods seems very apt. Unfortunately, it feels like "the beginning" was more a test than a long-term change.
Last updated: February 10, 2012: 08:09 AM
Hot Stocks
DailyFinance Headlines
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
Benzinga Headlines
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
- The Pepsi Challenge for 8,700 People is to Find a New Job
- How to Profit From Surging Chinese Prices
- Credit Suisse is the Latest Swiss Bank to Disappoint
TheFlyOnTheWall.com Headlines
- Lorillard price target raised to $140 from $124 at UBS
- Arch Coal reports Q4 EPS 29c vs. consensus 32c
- Apple iTunes customers receiving refunds following hack attacks, CNET says
- The FDA Cellular, Tissue & Gene Therapies Committee is hosting a teleconference
- ADA-ES management to meet with Lazard Capital
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Savings Experiment: Snow Removal


Reader Comments (Page 1 of 1)
12-08-2007 @ 1:15AM
Mur said...
It's right! Radiohead right now. http://www.mp3tape.com/radiohead/art1115/